• Keine Ergebnisse gefunden

Figure S1. Progression-free survival and overall survival in the ALDH1

N/A
N/A
Info
Herunterladen
Protected

Academic year: 2022

Aktie "Figure S1. Progression-free survival and overall survival in the ALDH1"

Copied!
3
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Jetzt herunterladen ( 3 Seite )

Volltext

(1)

Figure S1. Progression-free survival and overall survival in the ALDH1+ population. Kaplan-Meier estimates of PFS according to RECIST 1.1 and IRR evaluation (A) and OS (B) among subjects in the ITT population with ALDH1+ CSC in metastatic tissue. Stratified hazard ratios for disease progression or death (PFS) and death (OS) are reported along with p values. Tick marks indicate censored data.

Figure S2. Progression-free survival and overall survival in the CD24-/CD44+ population. Kaplan-Meier estimates of PFS according to RECIST 1.1 and IRR evaluation (A) and OS (B) among subjects in the ITT population with CD24-/CD44+ CSC in metastatic tissue. Stratified hazard ratios for disease progression or death (in analysis of PFS) or death (in analysis of OS) are reported along with p values. Tick marks indicate censored data.

Figure S1. ALDH-1+

A

B

(2)

Figure S2. CD24-/CD44+

A

(3)

B

Referenzen

Jetzt herunterladen ( DOCX - 3 Seite - 228.20 KB )

ÄHNLICHE DOKUMENTE

AcidCeramidase(AC)—AKeyEnzymeofSphingolipidMetabolism—CorrelatesWithBetterPrognosisinEpithelialOvarianCancer OriginalArticle

Kaplan-Meier analyses of progression-free survival (A) and overall survival (B) were performed in patients with serous epithelial ovarian cancer on the basis of AC

event free survival event free survival

NewYork Edinburgh EORTC Frankfurt Rotterdam MDA133 Frankfurt_2 San_Francisco Genentech Stockholm TransBIG Signapore expO Frankfurt_3 London Oxford_Untr… Veridex_Tam Mainz Uppsala

Die Therapielandschaft des fortgeschrittenen Urothelkarzinoms

1L, first-line; M-CAVI, methotrexate, carboplatin, and vinblastine; MVAC, methotrexate, vinblastine, doxorubicin, and cisplatin; OS, overall survival; PFS, progression-free

Prognostic nomogram to predict the overall survival of patients with early‑onset colorectal cancer: a population‑based analysis

Therefore, the present study aimed to identify clinico- pathological and socio-economic prognostic factors associ- ated with overall survival of EO-CRC patients using a large

Studies on the role of Coronin 1 and the actin cytoskeleton in T cell signaling and survival

MHC class ǿǿ molecules are mainly expressed on the surface of professional antigen presenting cells, such as macrophages, neutrophiles, dendritic cells and B cell but can be

LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype

In compared to without methylation changes, LINE-1 hypomethylation was significantly correlated with shorter HCC survival (median survival 41 and 490 weeks respectively, log

Figure S1. Subjects participating in the JDCP study

Hyphens indicate no estimation due to too small a number of observed events in a subgroup to develop a reliable regression model.. CVD, cardiovascular disease;

Kaplan-Meier curves for overall survival (A) and progression-free survival (B) for all patients (TAS cohort). One patient was excluded from the PFS analysis due to missing follow up.

Survival analyses according to the Kaplan-Meier Method.. One patient was excluded from the PFS analysis due to missing